Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg
(EVP, Chief Technical Officer) |
S | Common Stock | D | 5278 | $66.37 - $66.37 | $350,323 |
| 2024-10-31 | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg
(EVP, Chief Technical Officer) |
A | Common Stock | A | 55 | $56.01 - $56.01 | $3,080 |
| 2024-09-13 | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J
(President, Worldwide R&D) |
F | Common Stock | D | 12098 | $84.90 - $84.90 | $1,027,120 |
| 2024-04-30 | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J
(President, Worldwide R&D) |
A | Common Stock | A | 300 | $68.65 - $68.65 | $20,593 |
| 2024-08-13 | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin
(GVP, Chief Accounting Officer) |
S | Common Stock | D | 714 | $90.00 - $90.00 | $64,260 |
| 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | MEIER RICHARD A
(Director) |
M | Common Stock | A | 6600 | $63.10 - $63.10 | $416,460 |
| 2024-06-03 | BIOMARIN PHARMACEUTICAL INC | MEIER RICHARD A
(Director) |
F | Common Stock | D | 5451 | $76.41 - $76.41 | $416,510 |
| 2024-05-30 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
S | Common Stock | D | 5000 | $75.19 - $75.19 | $375,950 |
| 2024-05-30 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
M | Common Stock | A | 5000 | $63.10 - $63.10 | $315,500 |
| 2024-04-30 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
A | Common Stock | A | 300 | $68.65 - $68.65 | $20,593 |
| 2024-05-28 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
S | Common Stock | D | 40850 | $74.45 - $75.29 | $3,043,801 |
| 2024-05-28 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
M | Common Stock | A | 40850 | $63.10 - $63.10 | $2,577,635 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |